Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

SAMHD1 does it again, now in resting T cells

Nature Medicine volume 18, pages 1611–1612 (2012)Cite this article

Subjects

A long-standing question in the HIV field is why HIV-1 fails to replicate in resting CD4+ T cells. A new study shows that host deoxynucleoside triphosphate triphosphohydrolase (dNTPase) sterile α motif and histidine/aspartic domain–containing protein 1 (SAMHD1), previously shown to block HIV infection in myeloid cells, also restricts HIV replication in resting CD4+ T cells by hydrolyzing dNTPs, which are needed for reverse transcription of the virus (pages 1682–1687).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: SAMHD1 restricts HIV-1 replication in resting CD4+ T cells by reducing dNTP concentrations needed for reverse transcription.

References

  1. Zack, J.A. et al. Cell 61, 213–222 (1990).

    Article  CAS  Google Scholar 

  2. Plesa, G. et al. J. Virol. 81, 13938–13942 (2007).

    Article  CAS  Google Scholar 

  3. Baldauf, H.-M. et al. Nat. Med. 18, 1682–1687 (2012)

    Article  CAS  Google Scholar 

  4. Rice, G. et al. Nat. Genet. 41, 829–832 (2009).

    Article  CAS  Google Scholar 

  5. Laguette, N. et al. Nature 474, 654–657 (2011).

    Article  CAS  Google Scholar 

  6. Hrecka, K. et al. Nature 474, 658–661 (2011).

    Article  CAS  Google Scholar 

  7. Lahouassa, H. et al. Nat. Immunol. 13, 223–228 (2012).

    Article  CAS  Google Scholar 

  8. Berger, A. et al. PLoS Pathog. 7, e1002425 (2011).

    Article  CAS  Google Scholar 

  9. Hofmann, H. et al. J Virol. published online, doi:10.1128/JVI.01657-12 (2012).

  10. Laguette, N. et al. Cell Host Microbe 11, 205–217 (2012).

    Article  CAS  Google Scholar 

  11. Sunseri, N., O'Brien, M., Bhardwaj, N. & Landau, N.R. J. Virol. 85, 6263–6274 (2011).

    Article  CAS  Google Scholar 

  12. Gibbs, J.S. et al. J. Virol. 69, 2378–2383 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Manel, N. et al. Nature 467, 214–217 (2010).

    Article  CAS  Google Scholar 

  14. Yan, N., Regalado-Magdos, A.D., Stiggelbout, B., Lee-Kirsch, M.A. & Lieberman, J. Nat. Immunol. 11, 1005–1013 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nan Yan is in the Department of Internal Medicine and Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.,

    Nan Yan

  2. and Department of Pediatrics, Judy Lieberman is in the Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.,

    Judy Lieberman

Authors
  1. Nan Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judy Lieberman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Nan Yan or Judy Lieberman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yan, N., Lieberman, J. SAMHD1 does it again, now in resting T cells. Nat Med 18, 1611–1612 (2012). https://doi.org/10.1038/nm.2980

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2980

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing